Global Cardiac Monitoring Market

Cardiac Monitoring Comprehensive Study by Type (ECG Monitor, Event Recorder, Implantable Cardiac Loop Recorder, Pacemaker, Defibrillator, Cardiac Resynchronization Therapy (CRT) Devices, Smart Wearable, Other), Application (Hospital, Household), End User (Hospitals and Clinics, Home Care Settings, Ambulatory Surgical Centers) Players and Region - Global Market Outlook to 2026

Cardiac Monitoring Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 5.2%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
The global Cardiac Monitoring market is expected to witness high growth in the forecasted period due to increasing incidences of cardiac diseases. Cardiac monitoring is the process of continuous or intermittent monitoring of heart activity, generally by electrocardiography, with an assessment of the patient's condition relative to their cardiac rhythm. It is one of the most reliable and efficient options for the monitoring of various cardiac conditions. the global market is driven by an increasingly aging population who are very susceptible to coronary heart diseases, growth in the prevalence of heart diseases, technological developments in cardiac monitoring devices that minimize the chances of infection, and improved efficiency of devices.

AttributesDetails
Study Period2017-2027
Base Year2021
High Growth MarketAsia Pacific
UnitValue (USD Million)
Key Companies ProfiledMedtronic (Ireland), Boston Scientific (United States), Abbott Laboratories (United States), GE Healthcare (United States), BIOTRONIK (Germany), Hill-Rom Holding (United States), Koninklijke Philips (Netherlands), iRhythm Technologies Inc (United States) and Livanova (United Kingdom)


According to AMA, the market for Cardiac Monitoring is expected to register a CAGR of 5.2% during the forecast period to 2027. This growth is primarily driven by Increasing Concern of Cardiovascular Diseases and Growing Inclination towards Wearable Cardiac Devices.

Globally, a noticeable market trend is evident Demand for Home-based, Point of Care, and Remote Monitoring Cardiac Systems The Health Care Technology sector in the North America region has been increasing at a sustainable rate, and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Medtronic (Ireland), Boston Scientific (United States), Abbott Laboratories (United States), GE Healthcare (United States), BIOTRONIK (Germany), Hill-Rom Holding (United States), Koninklijke Philips (Netherlands), iRhythm Technologies Inc (United States) and Livanova (United Kingdom), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
On15th July 2019, BIOTRONIK received FDA Clearance for the BIOMONITOR III injectable cardiac monitor (ICM). BioMonitor III is designed to document suspected arrhythmia or unexplained syncope with increased clarity, enabling fast diagnosis and appropriate treatment.
On 15th March 2019, Biotronik announced U.S. Food and Drug Administration (FDA) approval of the Acticor and Rivacor high-voltage cardiac rhythm management (CRM) device families for the treatment of patients with cardiac arrhythmias.

Influencing Trend:
Demand for Home-based, Point of Care, and Remote Monitoring Cardiac Systems and Increasing Expenditure, Funds, and Grants for Research on CM & CRM Devices

Market Growth Drivers:
Increasing Concern of Cardiovascular Diseases and Growing Inclination towards Wearable Cardiac Devices

Challenges:
Unfavorable Reimbursement Policies and Frequent Product Recalls

Restraints:
Growing Concern Regarding Risk of Infection Due to Implantable Monitoring Devices and Increasing Incidences of Cied Infections

Opportunities:
Growing Demand due to Technological Advancement

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints in Cardiac Monitoring Market
- Analysis about New Entrants in Cardiac Monitoring Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
- An Unbiased Perspective towards Market Performance & Indicators

Against this Challenging Backdrop, Cardiac Monitoring Study Sheds Light on
— The Cardiac Monitoring Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Cardiac Monitoring industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Cardiac Monitoring industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • ECG Monitor
  • Event Recorder
  • Implantable Cardiac Loop Recorder
  • Pacemaker
  • Defibrillator
  • Cardiac Resynchronization Therapy (CRT) Devices
  • Smart Wearable
  • Other
By Application
  • Hospital
  • Household
By End User
  • Hospitals and Clinics
  • Home Care Settings
  • Ambulatory Surgical Centers

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Concern of Cardiovascular Diseases
      • 3.2.2. Growing Inclination towards Wearable Cardiac Devices
    • 3.3. Market Challenges
      • 3.3.1. Unfavorable Reimbursement Policies
      • 3.3.2. Frequent Product Recalls
    • 3.4. Market Trends
      • 3.4.1. Demand for Home-based, Point of Care, and Remote Monitoring Cardiac Systems
      • 3.4.2. Increasing Expenditure, Funds, and Grants for Research on CM & CRM Devices
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Cardiac Monitoring, by Type, Application, End User and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Cardiac Monitoring (Value)
      • 5.2.1. Global Cardiac Monitoring by: Type (Value)
        • 5.2.1.1. ECG Monitor
        • 5.2.1.2. Event Recorder
        • 5.2.1.3. Implantable Cardiac Loop Recorder
        • 5.2.1.4. Pacemaker
        • 5.2.1.5. Defibrillator
        • 5.2.1.6. Cardiac Resynchronization Therapy (CRT) Devices
        • 5.2.1.7. Smart Wearable
        • 5.2.1.8. Other
      • 5.2.2. Global Cardiac Monitoring by: Application (Value)
        • 5.2.2.1. Hospital
        • 5.2.2.2. Household
      • 5.2.3. Global Cardiac Monitoring by: End User (Value)
        • 5.2.3.1. Hospitals and Clinics
        • 5.2.3.2. Home Care Settings
        • 5.2.3.3. Ambulatory Surgical Centers
      • 5.2.4. Global Cardiac Monitoring Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Cardiac Monitoring (Price)
      • 5.3.1. Global Cardiac Monitoring by: Type (Price)
  • 6. Cardiac Monitoring: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Medtronic (Ireland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Boston Scientific (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Abbott Laboratories (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. GE Healthcare (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. BIOTRONIK (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Hill-Rom Holding (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Koninklijke Philips (Netherlands)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. IRhythm Technologies Inc (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Livanova (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Cardiac Monitoring Sale, by Type, Application, End User and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Cardiac Monitoring (Value)
      • 7.2.1. Global Cardiac Monitoring by: Type (Value)
        • 7.2.1.1. ECG Monitor
        • 7.2.1.2. Event Recorder
        • 7.2.1.3. Implantable Cardiac Loop Recorder
        • 7.2.1.4. Pacemaker
        • 7.2.1.5. Defibrillator
        • 7.2.1.6. Cardiac Resynchronization Therapy (CRT) Devices
        • 7.2.1.7. Smart Wearable
        • 7.2.1.8. Other
      • 7.2.2. Global Cardiac Monitoring by: Application (Value)
        • 7.2.2.1. Hospital
        • 7.2.2.2. Household
      • 7.2.3. Global Cardiac Monitoring by: End User (Value)
        • 7.2.3.1. Hospitals and Clinics
        • 7.2.3.2. Home Care Settings
        • 7.2.3.3. Ambulatory Surgical Centers
      • 7.2.4. Global Cardiac Monitoring Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Cardiac Monitoring (Price)
      • 7.3.1. Global Cardiac Monitoring by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Cardiac Monitoring: by Type(USD Million)
  • Table 2. Cardiac Monitoring ECG Monitor , by Region USD Million (2016-2021)
  • Table 3. Cardiac Monitoring Event Recorder , by Region USD Million (2016-2021)
  • Table 4. Cardiac Monitoring Implantable Cardiac Loop Recorder , by Region USD Million (2016-2021)
  • Table 5. Cardiac Monitoring Pacemaker , by Region USD Million (2016-2021)
  • Table 6. Cardiac Monitoring Defibrillator , by Region USD Million (2016-2021)
  • Table 7. Cardiac Monitoring Cardiac Resynchronization Therapy (CRT) Devices , by Region USD Million (2016-2021)
  • Table 8. Cardiac Monitoring Smart Wearable , by Region USD Million (2016-2021)
  • Table 9. Cardiac Monitoring Other , by Region USD Million (2016-2021)
  • Table 10. Cardiac Monitoring: by Application(USD Million)
  • Table 11. Cardiac Monitoring Hospital , by Region USD Million (2016-2021)
  • Table 12. Cardiac Monitoring Household , by Region USD Million (2016-2021)
  • Table 13. Cardiac Monitoring: by End User(USD Million)
  • Table 14. Cardiac Monitoring Hospitals and Clinics , by Region USD Million (2016-2021)
  • Table 15. Cardiac Monitoring Home Care Settings , by Region USD Million (2016-2021)
  • Table 16. Cardiac Monitoring Ambulatory Surgical Centers , by Region USD Million (2016-2021)
  • Table 17. South America Cardiac Monitoring, by Country USD Million (2016-2021)
  • Table 18. South America Cardiac Monitoring, by Type USD Million (2016-2021)
  • Table 19. South America Cardiac Monitoring, by Application USD Million (2016-2021)
  • Table 20. South America Cardiac Monitoring, by End User USD Million (2016-2021)
  • Table 21. Brazil Cardiac Monitoring, by Type USD Million (2016-2021)
  • Table 22. Brazil Cardiac Monitoring, by Application USD Million (2016-2021)
  • Table 23. Brazil Cardiac Monitoring, by End User USD Million (2016-2021)
  • Table 24. Argentina Cardiac Monitoring, by Type USD Million (2016-2021)
  • Table 25. Argentina Cardiac Monitoring, by Application USD Million (2016-2021)
  • Table 26. Argentina Cardiac Monitoring, by End User USD Million (2016-2021)
  • Table 27. Rest of South America Cardiac Monitoring, by Type USD Million (2016-2021)
  • Table 28. Rest of South America Cardiac Monitoring, by Application USD Million (2016-2021)
  • Table 29. Rest of South America Cardiac Monitoring, by End User USD Million (2016-2021)
  • Table 30. Asia Pacific Cardiac Monitoring, by Country USD Million (2016-2021)
  • Table 31. Asia Pacific Cardiac Monitoring, by Type USD Million (2016-2021)
  • Table 32. Asia Pacific Cardiac Monitoring, by Application USD Million (2016-2021)
  • Table 33. Asia Pacific Cardiac Monitoring, by End User USD Million (2016-2021)
  • Table 34. China Cardiac Monitoring, by Type USD Million (2016-2021)
  • Table 35. China Cardiac Monitoring, by Application USD Million (2016-2021)
  • Table 36. China Cardiac Monitoring, by End User USD Million (2016-2021)
  • Table 37. Japan Cardiac Monitoring, by Type USD Million (2016-2021)
  • Table 38. Japan Cardiac Monitoring, by Application USD Million (2016-2021)
  • Table 39. Japan Cardiac Monitoring, by End User USD Million (2016-2021)
  • Table 40. India Cardiac Monitoring, by Type USD Million (2016-2021)
  • Table 41. India Cardiac Monitoring, by Application USD Million (2016-2021)
  • Table 42. India Cardiac Monitoring, by End User USD Million (2016-2021)
  • Table 43. South Korea Cardiac Monitoring, by Type USD Million (2016-2021)
  • Table 44. South Korea Cardiac Monitoring, by Application USD Million (2016-2021)
  • Table 45. South Korea Cardiac Monitoring, by End User USD Million (2016-2021)
  • Table 46. Taiwan Cardiac Monitoring, by Type USD Million (2016-2021)
  • Table 47. Taiwan Cardiac Monitoring, by Application USD Million (2016-2021)
  • Table 48. Taiwan Cardiac Monitoring, by End User USD Million (2016-2021)
  • Table 49. Australia Cardiac Monitoring, by Type USD Million (2016-2021)
  • Table 50. Australia Cardiac Monitoring, by Application USD Million (2016-2021)
  • Table 51. Australia Cardiac Monitoring, by End User USD Million (2016-2021)
  • Table 52. Rest of Asia-Pacific Cardiac Monitoring, by Type USD Million (2016-2021)
  • Table 53. Rest of Asia-Pacific Cardiac Monitoring, by Application USD Million (2016-2021)
  • Table 54. Rest of Asia-Pacific Cardiac Monitoring, by End User USD Million (2016-2021)
  • Table 55. Europe Cardiac Monitoring, by Country USD Million (2016-2021)
  • Table 56. Europe Cardiac Monitoring, by Type USD Million (2016-2021)
  • Table 57. Europe Cardiac Monitoring, by Application USD Million (2016-2021)
  • Table 58. Europe Cardiac Monitoring, by End User USD Million (2016-2021)
  • Table 59. Germany Cardiac Monitoring, by Type USD Million (2016-2021)
  • Table 60. Germany Cardiac Monitoring, by Application USD Million (2016-2021)
  • Table 61. Germany Cardiac Monitoring, by End User USD Million (2016-2021)
  • Table 62. France Cardiac Monitoring, by Type USD Million (2016-2021)
  • Table 63. France Cardiac Monitoring, by Application USD Million (2016-2021)
  • Table 64. France Cardiac Monitoring, by End User USD Million (2016-2021)
  • Table 65. Italy Cardiac Monitoring, by Type USD Million (2016-2021)
  • Table 66. Italy Cardiac Monitoring, by Application USD Million (2016-2021)
  • Table 67. Italy Cardiac Monitoring, by End User USD Million (2016-2021)
  • Table 68. United Kingdom Cardiac Monitoring, by Type USD Million (2016-2021)
  • Table 69. United Kingdom Cardiac Monitoring, by Application USD Million (2016-2021)
  • Table 70. United Kingdom Cardiac Monitoring, by End User USD Million (2016-2021)
  • Table 71. Netherlands Cardiac Monitoring, by Type USD Million (2016-2021)
  • Table 72. Netherlands Cardiac Monitoring, by Application USD Million (2016-2021)
  • Table 73. Netherlands Cardiac Monitoring, by End User USD Million (2016-2021)
  • Table 74. Rest of Europe Cardiac Monitoring, by Type USD Million (2016-2021)
  • Table 75. Rest of Europe Cardiac Monitoring, by Application USD Million (2016-2021)
  • Table 76. Rest of Europe Cardiac Monitoring, by End User USD Million (2016-2021)
  • Table 77. MEA Cardiac Monitoring, by Country USD Million (2016-2021)
  • Table 78. MEA Cardiac Monitoring, by Type USD Million (2016-2021)
  • Table 79. MEA Cardiac Monitoring, by Application USD Million (2016-2021)
  • Table 80. MEA Cardiac Monitoring, by End User USD Million (2016-2021)
  • Table 81. Middle East Cardiac Monitoring, by Type USD Million (2016-2021)
  • Table 82. Middle East Cardiac Monitoring, by Application USD Million (2016-2021)
  • Table 83. Middle East Cardiac Monitoring, by End User USD Million (2016-2021)
  • Table 84. Africa Cardiac Monitoring, by Type USD Million (2016-2021)
  • Table 85. Africa Cardiac Monitoring, by Application USD Million (2016-2021)
  • Table 86. Africa Cardiac Monitoring, by End User USD Million (2016-2021)
  • Table 87. North America Cardiac Monitoring, by Country USD Million (2016-2021)
  • Table 88. North America Cardiac Monitoring, by Type USD Million (2016-2021)
  • Table 89. North America Cardiac Monitoring, by Application USD Million (2016-2021)
  • Table 90. North America Cardiac Monitoring, by End User USD Million (2016-2021)
  • Table 91. United States Cardiac Monitoring, by Type USD Million (2016-2021)
  • Table 92. United States Cardiac Monitoring, by Application USD Million (2016-2021)
  • Table 93. United States Cardiac Monitoring, by End User USD Million (2016-2021)
  • Table 94. Canada Cardiac Monitoring, by Type USD Million (2016-2021)
  • Table 95. Canada Cardiac Monitoring, by Application USD Million (2016-2021)
  • Table 96. Canada Cardiac Monitoring, by End User USD Million (2016-2021)
  • Table 97. Mexico Cardiac Monitoring, by Type USD Million (2016-2021)
  • Table 98. Mexico Cardiac Monitoring, by Application USD Million (2016-2021)
  • Table 99. Mexico Cardiac Monitoring, by End User USD Million (2016-2021)
  • Table 100. Cardiac Monitoring: by Type(USD/Units)
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Cardiac Monitoring: by Type(USD Million)
  • Table 111. Cardiac Monitoring ECG Monitor , by Region USD Million (2022-2027)
  • Table 112. Cardiac Monitoring Event Recorder , by Region USD Million (2022-2027)
  • Table 113. Cardiac Monitoring Implantable Cardiac Loop Recorder , by Region USD Million (2022-2027)
  • Table 114. Cardiac Monitoring Pacemaker , by Region USD Million (2022-2027)
  • Table 115. Cardiac Monitoring Defibrillator , by Region USD Million (2022-2027)
  • Table 116. Cardiac Monitoring Cardiac Resynchronization Therapy (CRT) Devices , by Region USD Million (2022-2027)
  • Table 117. Cardiac Monitoring Smart Wearable , by Region USD Million (2022-2027)
  • Table 118. Cardiac Monitoring Other , by Region USD Million (2022-2027)
  • Table 119. Cardiac Monitoring: by Application(USD Million)
  • Table 120. Cardiac Monitoring Hospital , by Region USD Million (2022-2027)
  • Table 121. Cardiac Monitoring Household , by Region USD Million (2022-2027)
  • Table 122. Cardiac Monitoring: by End User(USD Million)
  • Table 123. Cardiac Monitoring Hospitals and Clinics , by Region USD Million (2022-2027)
  • Table 124. Cardiac Monitoring Home Care Settings , by Region USD Million (2022-2027)
  • Table 125. Cardiac Monitoring Ambulatory Surgical Centers , by Region USD Million (2022-2027)
  • Table 126. South America Cardiac Monitoring, by Country USD Million (2022-2027)
  • Table 127. South America Cardiac Monitoring, by Type USD Million (2022-2027)
  • Table 128. South America Cardiac Monitoring, by Application USD Million (2022-2027)
  • Table 129. South America Cardiac Monitoring, by End User USD Million (2022-2027)
  • Table 130. Brazil Cardiac Monitoring, by Type USD Million (2022-2027)
  • Table 131. Brazil Cardiac Monitoring, by Application USD Million (2022-2027)
  • Table 132. Brazil Cardiac Monitoring, by End User USD Million (2022-2027)
  • Table 133. Argentina Cardiac Monitoring, by Type USD Million (2022-2027)
  • Table 134. Argentina Cardiac Monitoring, by Application USD Million (2022-2027)
  • Table 135. Argentina Cardiac Monitoring, by End User USD Million (2022-2027)
  • Table 136. Rest of South America Cardiac Monitoring, by Type USD Million (2022-2027)
  • Table 137. Rest of South America Cardiac Monitoring, by Application USD Million (2022-2027)
  • Table 138. Rest of South America Cardiac Monitoring, by End User USD Million (2022-2027)
  • Table 139. Asia Pacific Cardiac Monitoring, by Country USD Million (2022-2027)
  • Table 140. Asia Pacific Cardiac Monitoring, by Type USD Million (2022-2027)
  • Table 141. Asia Pacific Cardiac Monitoring, by Application USD Million (2022-2027)
  • Table 142. Asia Pacific Cardiac Monitoring, by End User USD Million (2022-2027)
  • Table 143. China Cardiac Monitoring, by Type USD Million (2022-2027)
  • Table 144. China Cardiac Monitoring, by Application USD Million (2022-2027)
  • Table 145. China Cardiac Monitoring, by End User USD Million (2022-2027)
  • Table 146. Japan Cardiac Monitoring, by Type USD Million (2022-2027)
  • Table 147. Japan Cardiac Monitoring, by Application USD Million (2022-2027)
  • Table 148. Japan Cardiac Monitoring, by End User USD Million (2022-2027)
  • Table 149. India Cardiac Monitoring, by Type USD Million (2022-2027)
  • Table 150. India Cardiac Monitoring, by Application USD Million (2022-2027)
  • Table 151. India Cardiac Monitoring, by End User USD Million (2022-2027)
  • Table 152. South Korea Cardiac Monitoring, by Type USD Million (2022-2027)
  • Table 153. South Korea Cardiac Monitoring, by Application USD Million (2022-2027)
  • Table 154. South Korea Cardiac Monitoring, by End User USD Million (2022-2027)
  • Table 155. Taiwan Cardiac Monitoring, by Type USD Million (2022-2027)
  • Table 156. Taiwan Cardiac Monitoring, by Application USD Million (2022-2027)
  • Table 157. Taiwan Cardiac Monitoring, by End User USD Million (2022-2027)
  • Table 158. Australia Cardiac Monitoring, by Type USD Million (2022-2027)
  • Table 159. Australia Cardiac Monitoring, by Application USD Million (2022-2027)
  • Table 160. Australia Cardiac Monitoring, by End User USD Million (2022-2027)
  • Table 161. Rest of Asia-Pacific Cardiac Monitoring, by Type USD Million (2022-2027)
  • Table 162. Rest of Asia-Pacific Cardiac Monitoring, by Application USD Million (2022-2027)
  • Table 163. Rest of Asia-Pacific Cardiac Monitoring, by End User USD Million (2022-2027)
  • Table 164. Europe Cardiac Monitoring, by Country USD Million (2022-2027)
  • Table 165. Europe Cardiac Monitoring, by Type USD Million (2022-2027)
  • Table 166. Europe Cardiac Monitoring, by Application USD Million (2022-2027)
  • Table 167. Europe Cardiac Monitoring, by End User USD Million (2022-2027)
  • Table 168. Germany Cardiac Monitoring, by Type USD Million (2022-2027)
  • Table 169. Germany Cardiac Monitoring, by Application USD Million (2022-2027)
  • Table 170. Germany Cardiac Monitoring, by End User USD Million (2022-2027)
  • Table 171. France Cardiac Monitoring, by Type USD Million (2022-2027)
  • Table 172. France Cardiac Monitoring, by Application USD Million (2022-2027)
  • Table 173. France Cardiac Monitoring, by End User USD Million (2022-2027)
  • Table 174. Italy Cardiac Monitoring, by Type USD Million (2022-2027)
  • Table 175. Italy Cardiac Monitoring, by Application USD Million (2022-2027)
  • Table 176. Italy Cardiac Monitoring, by End User USD Million (2022-2027)
  • Table 177. United Kingdom Cardiac Monitoring, by Type USD Million (2022-2027)
  • Table 178. United Kingdom Cardiac Monitoring, by Application USD Million (2022-2027)
  • Table 179. United Kingdom Cardiac Monitoring, by End User USD Million (2022-2027)
  • Table 180. Netherlands Cardiac Monitoring, by Type USD Million (2022-2027)
  • Table 181. Netherlands Cardiac Monitoring, by Application USD Million (2022-2027)
  • Table 182. Netherlands Cardiac Monitoring, by End User USD Million (2022-2027)
  • Table 183. Rest of Europe Cardiac Monitoring, by Type USD Million (2022-2027)
  • Table 184. Rest of Europe Cardiac Monitoring, by Application USD Million (2022-2027)
  • Table 185. Rest of Europe Cardiac Monitoring, by End User USD Million (2022-2027)
  • Table 186. MEA Cardiac Monitoring, by Country USD Million (2022-2027)
  • Table 187. MEA Cardiac Monitoring, by Type USD Million (2022-2027)
  • Table 188. MEA Cardiac Monitoring, by Application USD Million (2022-2027)
  • Table 189. MEA Cardiac Monitoring, by End User USD Million (2022-2027)
  • Table 190. Middle East Cardiac Monitoring, by Type USD Million (2022-2027)
  • Table 191. Middle East Cardiac Monitoring, by Application USD Million (2022-2027)
  • Table 192. Middle East Cardiac Monitoring, by End User USD Million (2022-2027)
  • Table 193. Africa Cardiac Monitoring, by Type USD Million (2022-2027)
  • Table 194. Africa Cardiac Monitoring, by Application USD Million (2022-2027)
  • Table 195. Africa Cardiac Monitoring, by End User USD Million (2022-2027)
  • Table 196. North America Cardiac Monitoring, by Country USD Million (2022-2027)
  • Table 197. North America Cardiac Monitoring, by Type USD Million (2022-2027)
  • Table 198. North America Cardiac Monitoring, by Application USD Million (2022-2027)
  • Table 199. North America Cardiac Monitoring, by End User USD Million (2022-2027)
  • Table 200. United States Cardiac Monitoring, by Type USD Million (2022-2027)
  • Table 201. United States Cardiac Monitoring, by Application USD Million (2022-2027)
  • Table 202. United States Cardiac Monitoring, by End User USD Million (2022-2027)
  • Table 203. Canada Cardiac Monitoring, by Type USD Million (2022-2027)
  • Table 204. Canada Cardiac Monitoring, by Application USD Million (2022-2027)
  • Table 205. Canada Cardiac Monitoring, by End User USD Million (2022-2027)
  • Table 206. Mexico Cardiac Monitoring, by Type USD Million (2022-2027)
  • Table 207. Mexico Cardiac Monitoring, by Application USD Million (2022-2027)
  • Table 208. Mexico Cardiac Monitoring, by End User USD Million (2022-2027)
  • Table 209. Cardiac Monitoring: by Type(USD/Units)
  • Table 210. Research Programs/Design for This Report
  • Table 211. Key Data Information from Secondary Sources
  • Table 212. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Cardiac Monitoring: by Type USD Million (2016-2021)
  • Figure 5. Global Cardiac Monitoring: by Application USD Million (2016-2021)
  • Figure 6. Global Cardiac Monitoring: by End User USD Million (2016-2021)
  • Figure 7. South America Cardiac Monitoring Share (%), by Country
  • Figure 8. Asia Pacific Cardiac Monitoring Share (%), by Country
  • Figure 9. Europe Cardiac Monitoring Share (%), by Country
  • Figure 10. MEA Cardiac Monitoring Share (%), by Country
  • Figure 11. North America Cardiac Monitoring Share (%), by Country
  • Figure 12. Global Cardiac Monitoring: by Type USD/Units (2016-2021)
  • Figure 13. Global Cardiac Monitoring share by Players 2021 (%)
  • Figure 14. Global Cardiac Monitoring share by Players (Top 3) 2021(%)
  • Figure 15. Global Cardiac Monitoring share by Players (Top 5) 2021(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 18. Medtronic (Ireland) Revenue: by Geography 2021
  • Figure 19. Boston Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 20. Boston Scientific (United States) Revenue: by Geography 2021
  • Figure 21. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 22. Abbott Laboratories (United States) Revenue: by Geography 2021
  • Figure 23. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 24. GE Healthcare (United States) Revenue: by Geography 2021
  • Figure 25. BIOTRONIK (Germany) Revenue, Net Income and Gross profit
  • Figure 26. BIOTRONIK (Germany) Revenue: by Geography 2021
  • Figure 27. Hill-Rom Holding (United States) Revenue, Net Income and Gross profit
  • Figure 28. Hill-Rom Holding (United States) Revenue: by Geography 2021
  • Figure 29. Koninklijke Philips (Netherlands) Revenue, Net Income and Gross profit
  • Figure 30. Koninklijke Philips (Netherlands) Revenue: by Geography 2021
  • Figure 31. IRhythm Technologies Inc (United States) Revenue, Net Income and Gross profit
  • Figure 32. IRhythm Technologies Inc (United States) Revenue: by Geography 2021
  • Figure 33. Livanova (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 34. Livanova (United Kingdom) Revenue: by Geography 2021
  • Figure 35. Global Cardiac Monitoring: by Type USD Million (2022-2027)
  • Figure 36. Global Cardiac Monitoring: by Application USD Million (2022-2027)
  • Figure 37. Global Cardiac Monitoring: by End User USD Million (2022-2027)
  • Figure 38. South America Cardiac Monitoring Share (%), by Country
  • Figure 39. Asia Pacific Cardiac Monitoring Share (%), by Country
  • Figure 40. Europe Cardiac Monitoring Share (%), by Country
  • Figure 41. MEA Cardiac Monitoring Share (%), by Country
  • Figure 42. North America Cardiac Monitoring Share (%), by Country
  • Figure 43. Global Cardiac Monitoring: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Medtronic (Ireland)
  • Boston Scientific (United States)
  • Abbott Laboratories (United States)
  • GE Healthcare (United States)
  • BIOTRONIK (Germany)
  • Hill-Rom Holding (United States)
  • Koninklijke Philips (Netherlands)
  • iRhythm Technologies Inc (United States)
  • Livanova (United Kingdom)
Select User Access Type

Key Highlights of Report


Dec 2021 245 Pages 63 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Cardiac Monitoring Market Quantitative research analysis
Global Cardiac Monitoring Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Cardiac Monitoring market are Medtronic (Ireland), Boston Scientific (United States), Abbott Laboratories (United States), GE Healthcare (United States), BIOTRONIK (Germany), Hill-Rom Holding (United States), Koninklijke Philips (Netherlands), iRhythm Technologies Inc (United States) and Livanova (United Kingdom), to name a few.
North America is dominating the Cardiac Monitoring Market.
"Unfavorable Reimbursement Policies " is seen as one of the major challenges by many Industry Players of Cardiac Monitoring Market
The Cardiac Monitoring market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get complete companies available in our research coverage.
The Cardiac Monitoring market is expected to see a steady growth rate during projected year 2021 to 2027.

Know More About Global Cardiac Monitoring Market Report?

Have a Query? Click Here

Other Related Reports

Nasal Drug Delivery Technology Comprehensive Study by Type (Multidose, Unit Dose, BI-Dose, Others), Application (Allergic & Non-allergic Rhinitis, Nasal Congestion, Asthma, Vaccination, Others), Dosa...
$ 3650
Artificial Intelligence In Diabetes Management Comprehensive Study by Application (Automated Retinal Screening, Clinical Decision Support, Predictive Population Risk Stratification, Patient Self-Mana...
$ 3750
Hyaluronic Acid Based Dermal Fillers Comprehensive Study by Type (Single-phase product, Duplex products), Application (Bootlegging, Sculpting, Fill Scars, Others), End User (Hospitals, Specialty Derm...
$ 3500
Ultraviolet Lamps Comprehensive Study by Type (High Boron Glass Lamp , Quartz Glass Lamp), Application (Sewage Treatment , Laboratory Uses , Hospital Uses), Treatment Type (Wastewater Treatment, Air ...
$ 3350
Serum Cancer Biomarkers Comprehensive Study by Type (Hepatocellular Carcinoma Serum Biomarkers, Lung Cancer Serum Biomarkers, Pancreatic and Biliary Tract Cancer Serum Biomarkers, Breast Cancer Serum...
$ 3750
Medical Oxygen Concentrators Comprehensive Study by Type (Portable Oxygen Concentrators, Stationary Oxygen Concentrators), Application (Hospitals, Home Care, Ambulatory Surgical Centers), Technology ...
$ 3450